Medium materiality6/10
TSHA: Taysha Gene Therapies price target raised to $14 from $10 at BMO Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update; target raised to $14 (from $10); current price $6.73.
- Target raised to $14; price $6.73.
Key facts
- 01
Target: $14
- 02
Posted price: $6.73
- 03
Analyst firm: Pivotal Research
- 04
Analyst: Keith Tapper
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.